Delivery Order SPE2DB20D2014-SPE2DB25FC65R
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Humalog 100 Unit/mL KwikPen 3mL insulin pens, with a ceiling value of $1,048.07. This is a firm fixed-price delivery order with an ultimate completion date of August 12, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Humalog 100 Unit/mL KwikPen 3mL insulin pens at a firm fixed price of $2,082.52, with an ultimate completion date of July 21, 2025. This is a non-set-aside, competitively awarded contract performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp on May 8, 2025, for the supply of Humalog 200 Unit/mL KwikPen 3mL insulin pens. This non-set-aside, competitively awarded delivery order carries a ceiling value of $1,098.24 under a firm fixed price arrangement, with an ultimate completion date of May 9, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its...
- The Defense Logistics Agency awarded a delivery order valued at $1,283.00 to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Humalog 200 Unit/mL KwikPen 3mL insulin pens. This is a firm fixed-price delivery order with no set-aside designation, completed competitively through open competition. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 19, 2025. This award represents a...
- The Defense Logistics Agency awarded a $1,243.46 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Humalog 100 Unit/mL KwikPen 3mL insulin pens. This is a non-set-aside contract with an ultimate completion date of August 20, 2025, and performance will be fulfilled from the contractor's location in Conshohocken, Pennsylvania. The delivery order represents a pharmaceutical supply transaction supporting military and federal healthcare systems'...
- The Defense Logistics Agency awarded a delivery order valued at $1,059.72 to AmerisourceBergen Drug Corp for the supply of Humalog 100 Unit/ML KwikPen 3ML insulin pens. This firm fixed-price delivery order, issued on August 25, 2025, with an ultimate completion date of August 26, 2025, represents a competitive award with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $6,581.08 delivery order to AmerisourceBergen Drug Corp for Humalog 100 Unit/mL KwikPen 3mL insulin pens, with an ultimate completion date of July 23, 2025. This non-set-aside contract represents a firm fixed price delivery under AmerisourceBergen's existing pharmaceutical supply framework with DLA. The contract will be performed at the company's corporate office location in Conshohocken, Pennsylvania. This delivery order operates under...
- The Defense Logistics Agency has awarded a delivery order valued at $1,685.41 to AmerisourceBergen Drug Corp for the supply of Humalog 100 Unit/mL KwikPen 3mL insulin pens. The contract is a firm fixed price delivery order with no set-aside designation, awarded on September 10, 2025, with an ultimate completion date of September 11, 2025. Performance will be executed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract...
- The Defense Logistics Agency awarded a $1,069.96 delivery order to AmerisourceBergen Drug Corp for Humalog 100 Unit/ML KwikPen 3ML insulin pens, with an ultimate completion date of July 22, 2025. This is a firm fixed price delivery order with no set-aside designation, issued competitively under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The product will be performed at AmerisourceBergen's Conshohocken, Pennsylvania location, where the company...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on September 4, 2025, for the supply of Humalog Jr 100 Unit/mL KwikPen 3mL insulin pens, valued at $4,020.86. This is a firm fixed-price delivery order with an ultimate completion date of September 5, 2025, and will be performed at the vendor's location in Conshohocken, Pennsylvania. The contract was competitively awarded without any set-aside designation, reflecting AmerisourceBergen's demonstrated...
- SPE2DB20D2014Indefinite Delivery Contract
- SPE2DB20D2014-SPE2DB25FC65RDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Humalog 100 Unit/mL KwikPen 3mL insulin pens with a ceiling value of $5,887.90. This is a firm fixed price delivery order with an ultimate completion date of August 6, 2025, and represents a non-compete, non-set-aside award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The work will be performed at the company's Corporate Office location in Conshohocken, PA. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen Drug Corp's contract awards demonstrate significant expertise in fulfilling federal medical supply needs across multiple therapeutic domains, with this insulin delivery representing part of its ongoing pharmaceutical support for the Defense Health Agency and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.9k | 8/5/25 |